Reported 60,000 shares, up 13,000 (27.7%) from the prior quarter.
Reported value -25.5%; share count 27.7% vs. the prior quarter.
Reported position value by quarter
Each bar is a Form 13-F quarter-end snapshot. It does not show trades made within the quarter.
| Date | Holding Value |
|---|---|
| 2025-09-30 | 3905372 |
| 2025-12-31 | 585960 |
| 2026-03-31 | 593140 |
| 2026-06-30 | 441600 |
| 2026-09-30 | 381000 |
Quarterly position history
How this manager's reported quarter-end position changed over time.
| Quarter | Activity | Shares | Change | % of reported 13F | Reported value | Filed | Source filing |
|---|---|---|---|---|---|---|---|
| Q3 2026 | Unchanged | 60,000 | 0 (0.0%) | < 0.01% | $381,000 | 2026-11-16 | |
| Q2 2026 | Added | 60,000 | +13,000 (27.7%) | < 0.01% | $441,600 | 2026-08-14 | |
| Q1 2026 | Reduced | 47,000 | -10,000 (-17.5%) | < 0.01% | $593,140 | 2026-05-15 | |
| Q4 2025 | Reduced | 57,000 | -10,334 (-15.3%) | < 0.01% | $585,960 | 2026-02-17 | |
| Q3 2025 | New | 67,334 | +67,334 (0.0%) | 0.04% | $3,905,372 | 2025-11-14 |
Who else reported the position
144 managers reported ENTRADA THERAPEUTICS INC for Q2 2026.
| Manager | Activity | Shares | Change | % of reported 13F | Reported value | Tenure |
|---|---|---|---|---|---|---|
| BAKER BROS ADVISORS LP | Unchanged | 5,072,730 | 0 | 0.19% | $37,335,293 | 19 qtrs |
| 5AM Venture Management LLC | Unchanged | 4,056,379 | 0 | 10.37% | $29,854,949 | 19 qtrs |
| BlackRock Inc | Added | 2,583,333 | +224,540 | < 0.01% | $19,013,332 | 8 qtrs |
| Merck & Co Inc | New | 1,739,768 | +1,739,768 | 2.43% | $12,804,692 | 1 qtr |
| VANGUARD CAPITAL MANAGEMENT LLC | Added | 1,269,634 | +13,621 | < 0.01% | $9,344,506 | 2 qtrs |
| BIOIMPACT CAPITAL LLC | New | 1,253,053 | +1,253,053 | 0.56% | $9,222,470 | 1 qtr |
| TCG Crossover Management LLC | Reduced | 1,060,230 | -1,227,270 | 0.19% | $7,803,293 | 19 qtrs |
| WELLINGTON MANAGEMENT GROUP LLP | Reduced | 954,419 | -80,363 | < 0.01% | $7,024,524 | 19 qtrs |
| MILLENNIUM MANAGEMENT LLC | Added | 763,959 | +244,603 | < 0.01% | $5,622,738 | 19 qtrs |
| StepStone Group LP | Unchanged | 761,277 | 0 | 0.26% | $5,602,999 | 19 qtrs |
Filing details and methodology As reported
- Report period
- June 30, 2026
- Filed
- August 14, 2026
- Filing type
- 13F-HR
- Position type
- COM
Voting authority reported
- Sole
- 0
- Shared
- 60,000
- None
- 0
“None” means the manager reported no voting authority for those shares on non-routine matters. It does not disclose why and is not evidence of securities lending.
Form 13-F is a delayed quarter-end snapshot of disclosed long Section 13(f) securities. It can be filed up to 45 days after quarter end, excludes short positions and most non-U.S. securities, and does not reveal intra-quarter trading. For options, reported shares and value describe the underlying-share exposure; strike, expiry, premium, and written positions are not disclosed.